Emilia K. Andersson

Solna, AB, Sweden

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 22 publications

Simlukafusp alfa (FAP-IL2v) plus atezolizumab with or without bevacizumab in unresectable, metastatic renal cell carcinoma: a randomized, open-label phase Ib study.

Simlukafusp alfa (FAP-IL2v) plus atezolizumab with or without bevacizumab in unresectable, metastatic renal cell carcinoma: a randomized, open-label phase Ib study.

Journal: Journal for immunotherapy of cancer

Published: February 02, 2026

Cergutuzumab Amunaleukin in Combination with Atezolizumab in Patients with Carcinoembryonic Antigen-Positive Advanced/Metastatic Solid Tumors.

Cergutuzumab Amunaleukin in Combination with Atezolizumab in Patients with Carcinoembryonic Antigen-Positive Advanced/Metastatic Solid Tumors.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: July 01, 2025

Investigating the complex interplay between fibroblast activation protein α-positive cancer associated fibroblasts and the tumor microenvironment in the context of cancer immunotherapy.

Investigating the complex interplay between fibroblast activation protein α-positive cancer associated fibroblasts and the tumor microenvironment in the context of cancer immunotherapy.

Journal: Frontiers in immunology

Published: December 08, 2023

Comprehensive analysis of fibroblast activation protein expression across 23 tumor indications: insights for biomarker development in cancer immunotherapies.

Comprehensive analysis of fibroblast activation protein expression across 23 tumor indications: insights for biomarker development in cancer immunotherapies.

Journal: Frontiers in immunology

Published: December 08, 2023

Multicenter International Study of the Consensus Immunoscore for the Prediction of Relapse and Survival in Early-Stage Colon Cancer.

Multicenter International Study of the Consensus Immunoscore for the Prediction of Relapse and Survival in Early-Stage Colon Cancer.

Journal: Cancers

Published: October 27, 2022

Clinical Performance of the Consensus Immunoscore in Colon Cancer in the Asian Population from the Multicenter International SITC Study.

Clinical Performance of the Consensus Immunoscore in Colon Cancer in the Asian Population from the Multicenter International SITC Study.

Journal: Cancers

Published: August 03, 2022

Tissue Selection for PD-L1 Testing in Triple Negative Breast Cancer (TNBC).

Tissue Selection for PD-L1 Testing in Triple Negative Breast Cancer (TNBC).

Journal: Applied immunohistochemistry & molecular morphology : AIMM

Published: December 28, 2021

The effectiveness of the colorectal cancer referral pathway - identification of colorectal cancer in a Swedish region.

The effectiveness of the colorectal cancer referral pathway - identification of colorectal cancer in a Swedish region.

Journal: Scandinavian journal of gastroenterology

Published: March 22, 2021

Multicenter International Society for Immunotherapy of Cancer Study of the Consensus Immunoscore for the Prediction of Survival and Response to Chemotherapy in Stage III Colon Cancer.

Multicenter International Society for Immunotherapy of Cancer Study of the Consensus Immunoscore for the Prediction of Survival and Response to Chemotherapy in Stage III Colon Cancer.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: September 08, 2020

Data-Driven Discovery of Immune Contexture Biomarkers.

Data-Driven Discovery of Immune Contexture Biomarkers.

Journal: Frontiers in oncology

Published: July 03, 2018

International validation of the consensus Immunoscore for the classification of colon cancer: a prognostic and accuracy study.

International validation of the consensus Immunoscore for the classification of colon cancer: a prognostic and accuracy study.

Journal: Lancet (London, England)

Published: December 29, 2017

Regulatory T-cell Genes Drive Altered Immune Microenvironment in Adult Solid Cancers and Allow for Immune Contextual Patient Subtyping.

Regulatory T-cell Genes Drive Altered Immune Microenvironment in Adult Solid Cancers and Allow for Immune Contextual Patient Subtyping.

Journal: Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology

Published: May 26, 2017

Showing 1-12 of 22

Last Updated: 09/26/2026